• Title of article

    Cytotoxicity of PAI2, C595 and Herceptin vectors labeled with the alpha-emitting radioisotope Bismuth-213 for ovarian cancer cell monolayers and clusters

  • Author/Authors

    Song، نويسنده , , Yan J. and Qu، نويسنده , , Chang F. and Rizvi، نويسنده , , Syed M.A. and Li، نويسنده , , Yong and Robertson، نويسنده , , G. P. Raja Sekhar، نويسنده , , Chand and Morgenstern، نويسنده , , Alfred and Apostolidis، نويسنده , , Christos and Perkins، نويسنده , , Alan C. and Allen، نويسنده , , Barry J.، نويسنده ,

  • Issue Information
    روزنامه با شماره پیاپی سال 2006
  • Pages
    8
  • From page
    176
  • To page
    183
  • Abstract
    The vectors PAI2, C595 and Herceptin target the membrane-bound uPA, MUC1 and HER2 antigens expressed by cancer cells, respectively. The expression of these receptors was tested in the ovarian cancer cell line OVCAR-3; MUC-1 was strongly expressed (3+), uPA moderately expressed (2+), but HER2 was negative (−). The α-emitting radionuclide Bismuth-213 was chelated with these targeting vectors to form alpha conjugates (ACs), the cytotoxicity of which were tested with OVCAR-3 cells. The PAI2 and C595 ACs are highly cytotoxic to the ovarian monolayer cancer cells and cell clusters in a concentration-dependent fashion and cause morphological changes of treated cancer cells, inducing apoptosis. These ACs are potential candidates for the control of ovarian cancer at the minimum residual disease (MRD) stage.
  • Keywords
    Radioimmunotherapy , Bismuth-213 , Ovarian cancer cell line , MUC1 , HER2 , uPA
  • Journal title
    Cancer Letters
  • Serial Year
    2006
  • Journal title
    Cancer Letters
  • Record number

    1809095